Navigation Links
Jazz Pharmaceuticals to Present Data From First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia
Date:6/9/2009

>

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments for important, underserved markets in neurology and psychiatry. For further information please see http://www.JazzPharmaceuticals.com.

Jazz Pharmaceuticals "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements related to the development of Jazz Pharmaceuticals' sodium oxybate (JZP-6) product candidate for the treatment of fibromyalgia, including the timing of results from the second Phase III pivotal clinical trial and the submission of a New Drug Application to the FDA. These forward-looking statements are based on the company's current expectations and inherently involve significant risks and uncertainties. Jazz Pharmaceuticals' actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to the outcomes of the company's second Phase III clinical study of sodium oxybate for the treatment of fibromyalgia and the timing of the announcement of clinical results, and risks that a New Drug Application may not be submitted, or may be delayed, and that sodium oxybate for the treatment of fibromyalgia may not be approved for marketing by regulatory authorities. These and other risk factors are discussed under "Risk Factors" in the Quarterly Report on Form 10-Q for the quarter ended March 31, 2009 filed by Jazz Pharmaceuticals with the Securities and Exchange Commission on May 7, 2009. Jazz Pharmaceuticals undertakes no duty or obligation to update any forward-l
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... (PRWEB) August 29, 2014 As a ... City, Fla., understands that there’s a direct connection between ... knees, hips and back. "Since conventional shoe inserts and ... a solution of my own," he said. , Customizable ... provides better support for the foot in order to ...
(Date:8/29/2014)... 29, 2014 Glendale Botox experts ... on Botox throughout the month of September. This special offer ... two syringes of Juvederm. Patients can take advantage of this ... The Glendale Botox experts will work with patients to determine ... What is Botox? , Botox is a treatment ...
(Date:8/29/2014)... (HealthDay News) -- The main strain of a ... and North Africa originated in sub-Saharan Africa, a ... methicillin-resistant Staphylococcus aureus (CA-MRSA) infections, which ... been hospitalized. These infections typically affect the skin ... through touching contaminated objects such as clothing or ...
(Date:8/29/2014)... 2014 (HealthDay News) -- The way that parents respond ... development, a new study suggests. Over six months, ... infants during free play. The sessions were 30 minutes ... 8 months old at the start of the study. ... babbling, infants began to form complex sounds. The babies ...
(Date:8/29/2014)... August 29, 2014 For the fifth ... (Meso Foundation) will be observing September 26th as Mesothelioma ... Plaza, in New York. , Members of the ... RSVP . The Foundation will be providing t-shirts and ... years, mesothelioma community members have received attention from ...
Breaking Medicine News(10 mins):Health News:Glenoaks Laser Center is Now Offering a Special Promotion on Botox for the Month of September 2Health News: European MRSA Originated in Sub-Saharan Africa, Study Finds 2Health News:Encouraging Your Baby's Babbling May Speed Language Development 2Health News:Organization to Raise Awareness of Mesothelioma on the Today Show 2
... mental function, study says , , THURSDAY, June 12 ... to fight cancer may reduce disease activity and disability ... small trial suggest. , In relapsing-remitting MS, the ... of symptoms followed by stretches of symptom-free remission when ...
... 12 Cancer Clinics of Excellence (CCE), the,nation,s ... has announced its management slate and Board of ... CCE. Most,recently, he was the interim President of ... Group was named Chief Medical,Officer. Dr. Bosserman had ...
... 12 Do you know a,Champion?, The ... working to improve Oklahoma,s health. The 2008 Champions ... are making a,significant difference in the health of ... Friday, Aug. 1., Nominations can be submitted ...
... June 12 The Arizona Board of Regents,recently ... of Arizona,College of Medicine Program in Integrative Medicine ... medicine has had on health-care,system transformation., Now ... (AzCIM), the,program underwent an intensive evaluation process and ...
... performance and lifestyle brand is paired with LensCrafters, ... 500 North American stores, MASON, Ohio, June ... at more than 500 select LensCrafters locations, North ... customers the,combined benefits of Oakley,s popular and innovative ...
... to call, write letters to Schwarzenegger,expressing their outrage, ... of home healthcare workers will rally to protest ... service, wages and,benefits. These dramatic reductions would force ... they serve deeper into poverty. It also,will force ...
Cached Medicine News:Health News:Cancer Drug Appears to Help With Aggressive MS 2Health News:Cancer Clinics of Excellence (CCE) Announces Management and Board of Directors Slate at 1st Annual General Membership Meeting 2Health News:Nominations Accepted for 2008 'Champions of Health' Awards 2Health News:The University of Arizona Program in Integrative Medicine Earns 'Center of Excellence' Designation 2Health News:The University of Arizona Program in Integrative Medicine Earns 'Center of Excellence' Designation 3Health News:Oakley Prescription Eyewear Now at Lenscrafters 2Health News:Oakley Prescription Eyewear Now at Lenscrafters 3Health News:Oakley Prescription Eyewear Now at Lenscrafters 4
(Date:8/28/2014)... 2014 Reportlinker.com announces that a ... its catalogue: Needle-Free Delivery: Technology ... http://www.reportlinker.com/p02332847/Needle-Free-Delivery-Technology-and-Market-Forecast-2014-2024.html Report Details ... commercial prospects What does the future hold ... new report shows you the potential revenues ...
(Date:8/28/2014)... , Aug. 28, 2014  Decision Resources Group ... will grow strongly through 2022 at a compound ... will be largely supported by strong population growth ... demand for imaging procedures. The Indian government,s greater ... facilities to purchase or upgrade diagnostic imaging equipment. ...
(Date:8/28/2014)... , Aug. 28, 2014 /PRNewswire-iReach/ -- EDGE Orthopaedics, ... space, is excited to announce they have received ... Plating System and REDUCE Fracture Plating System. ... used to support multiple indications within the mid-foot. ... First Metatarsophalangeal (MTP), Calcaneal-Cuboid (CC), Talonavicular (TN) and ...
Breaking Medicine Technology:Needle-Free Delivery: Technology and Market Forecast 2014-2024 2Needle-Free Delivery: Technology and Market Forecast 2014-2024 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 4Needle-Free Delivery: Technology and Market Forecast 2014-2024 5Needle-Free Delivery: Technology and Market Forecast 2014-2024 6Needle-Free Delivery: Technology and Market Forecast 2014-2024 7Needle-Free Delivery: Technology and Market Forecast 2014-2024 8Needle-Free Delivery: Technology and Market Forecast 2014-2024 9Needle-Free Delivery: Technology and Market Forecast 2014-2024 10Needle-Free Delivery: Technology and Market Forecast 2014-2024 11Needle-Free Delivery: Technology and Market Forecast 2014-2024 12Needle-Free Delivery: Technology and Market Forecast 2014-2024 13Needle-Free Delivery: Technology and Market Forecast 2014-2024 14Needle-Free Delivery: Technology and Market Forecast 2014-2024 15Needle-Free Delivery: Technology and Market Forecast 2014-2024 16Needle-Free Delivery: Technology and Market Forecast 2014-2024 17Needle-Free Delivery: Technology and Market Forecast 2014-2024 18Indian Diagnostic Imaging System Market Will Grow at 6 Percent Annually Through 2022 2Indian Diagnostic Imaging System Market Will Grow at 6 Percent Annually Through 2022 3EDGE Orthopaedics Receives Second FDA Clearance 2
... NEW YORK, Aug. 25 Reportlinker.com ... report is available in its catalogue: ... the Asia-Pacific Region – India and ... still dominates high value transactions ...
... (Nasdaq: BIOD ) today announced that it has ... 2,398,200 shares of its common stock and warrants to purchase ... warrants are being sold as units, with each unit consisting ... purchase one share of common stock.   The ...
Cached Medicine Technology:Reportlinker Adds Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions 2Reportlinker Adds Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions 3Reportlinker Adds Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions 4Reportlinker Adds Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions 5Reportlinker Adds Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions 6Reportlinker Adds Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions 7Reportlinker Adds Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions 8Reportlinker Adds Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions 9Biodel to Raise $9.4 Million Through Registered Direct Offering 2Biodel to Raise $9.4 Million Through Registered Direct Offering 3
... eye-nasal. High volume/low pressure cuff. X-ray ... surgical access. Designed to reduce kinking ... preformed curvature. Thin-walled, large volume low-pressure ... the anatomical situation at body temperature. ...
Ruschelit® PVC. Siliconized. Stainless steel spiral reinforced. High volume/low pressure cuff. Permanent connector. X-ray opaque. Single use. Sterile...
Tube for Right Bronchus - Ruschelit™ PVC. Color coded for easy identification of ports, balloons and 15mm connectors. High volume/low pressure cuffs. With Carina hook. X-ray opaque line. Gradua...
... For Laryngotracheal Instillation of Topical Anesthetic, ... populations, this cuffed tube incorporates an ... spray application of topical anesthetic above ... offers three endotracheal tubes designs which ...
Medicine Products: